BioSpace News Archive

Bausch Health Companies Inc. announced today that it has entered into an incremental term loan facility amendment (the “Incremental Amendment”) to its credit agreement, pursuant to which Valeant Pharmaceuticals International (“VPI”), a Delaware corporation and a wholly owned indirect subsidiary of the Company, borrowed $1,500,000,000 of new term B loans.

Aflac Incorporated announced today that Executive Vice President and Chief Financial Officer of Aflac Incorporated Frederick J. Crawford will participate in a fireside chat at the Goldman Sachs U.S. Financial Services Conference 2018 on December 4, 2018 at 3:30 p.m. ET.

Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today provides an AGM trading and regulatory update ahead of its Half Year Results to be announced in March 2019.

TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend” or the “Company”) is pleased to announce that its shareholders voted today to approve the previously announced plan of arrangement (the “Arrangement”), which will pave the way for TerrAscend to explore and pursue growth opportunities in the United States, including potential acquisitions of operators in states that have legalized cannabis for therapeutic or adult-use.

Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company, today reported that data from three abstracts—including an oral presentation—were accepted for presentation at the 60th American Society of Hematology Annual Meeting (ASH 2018)

Trial to focus on reduction of hemoglobin A1c for patients diagnosed with type 2 diabetes and obesity.

SQI Diagnostics Inc. (“SQI Diagnostics” or the “Company”) (TSX-V: SQD; OTCQB: SQIDF), today announced that it plans to release its financial and operational results for the fourth quarter and fiscal year ended September 30, 2018 at 5:00 p.m. ET Tuesday, December 11, 2018.

The American Diabetes Association (ADA) acknowledges Kivort Steel Diabetes Revolution, led and backed by Robert Kivort and captained by Howard Katz, for their efforts to support the Capital Region Tour de Cure® (Tour) and the ADA.

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Evercore ISI HealthConX Conference in Boston on Thursday, November 29th, at 11:00 a.m. ET.

Aidoc, a leading provider of AI solutions for radiologists, revealed today that their always-on solution for automatic flagging and prioritization of critical CT cases is in full use at the University of Rochester Medicine, saving lives by ensuring that urgent cases are quickly diagnosed and treated.